Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Named Patient Program With Rotigotine Transdermal System

ClinicalTrials.gov ID: NCT01095484

Public ClinicalTrials.gov record NCT01095484. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 1:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The named patient program will allow investigators to supply rotigotine transdermal system to patients who have a documented medical necessity to receive treatment with the drug.

Study identification

NCT ID
NCT01095484
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
UCB Pharma
Industry
Enrollment
520 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2008 (Type not available)
Primary completion
Dec 2012 (Actual)
Completion
Dec 2012 (Actual)
Last update posted
Oct 20, 2014

2008 – 2012

United States locations

U.S. sites
51
U.S. states
21
U.S. cities
49
Facility City State ZIP Site status
088 Birmingham Alabama — —
082 Cullman Alabama — —
085 Fairhope Alabama — —
014 Huntsville Alabama — —
097 Gilbert Arizona — —
003 Phoenix Arizona — —
044 Phoenix Arizona — —
036 Berkeley California — —
024 Fountain Valley California — —
034 Irvine California — —
019 Los Angeles California — —
040 Orange California — —
076 Sunnyvale California — —
035 Fort Collins Colorado — —
027 Washington D.C. District of Columbia — —
070 Atlantis Florida — —
002 Boca Raton Florida — —
031 Clearwater Florida — —
028 Largo Florida — —
075 Ormond Beach Florida — —
022 St. Petersburg Florida — —
004 Tampa Florida — —
054 Weston Florida — —
030 Atlanta Georgia — —
041 Honolulu Hawaii — —
011 Peoria Illinois — —
025 Destrehan Louisiana — —
091 Clinton Township Michigan — —
001 Southfield Michigan — —
042 Warren Michigan — —
037 Ocean Springs Mississippi — —
016 West Plains Missouri — —
026 Lincoln Nebraska — —
086 Freehold New Jersey — —
062 Ridgewood New Jersey — —
018 Albany New York — —
066 Brooklyn New York — —
006 Patchogue New York — —
052 Charlotte North Carolina — —
093 Salisbury North Carolina — —
065 Albany Oregon — —
009 Salem Oregon — —
048 Austin Texas — —
072 Austin Texas — —
071 Dallas Texas — —
046 Houston Texas — —
005 Kirkland Washington — —
017 Olympia Washington — —
012 Spokane Washington — —
053 Tacoma Washington — —
056 Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01095484, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2014 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01095484 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →